Form 4 for ACH ACCENDRA HEALTH INC/VA/

Accepted 2024-06-07 00:00:00 ET · period of report 2024-06-06 · accession 0001062993-24-012194 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2024-06-07	2024-06-06	ACH	Bernocchi Perry A	EVP, CEO, Patient Direct	S - Sale	$17.49	-20.0K	132.4K	-13%	-$350.0K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-06-06	S	D	10,756	$17.49	136,895	D	—	—	(F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 4, 2024. (F3) Weighted average of the sale price range of $17.285 - $17.78
2	Common	Common Stock	2024-06-06	S	D	2,833	$17.48	129,520	D	—	—	(F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 4, 2024. (F5) Weighted average of the sale price range of $17.30 - $17.75
3	Common	Common Stock	2024-06-06	S	D	1,884	$17.47	147,651	D	—	—	(F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 4, 2024. (F2) Weighted average of the sale price range of $17.30 - $17.76
4	Common	Common Stock	2024-06-06	S	D	4,542	$17.49	132,353	D	—	—	(F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 4, 2024. (F4) Weighted average of the sale price range of $17.30 - $17.77